The three-year collaboration will try to identify biomarkers that can eventually be used for targeted diagnostics and therapies.
New York City-based Mount Sinai Health System and King Saud University Medical City in Riyadh, Saudi Arabia, have launched a three-year research collaboration to study inflammatory bowel disease in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results